PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 104 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,601,833 | -10.9% | 347,332 | +23.0% | 0.96% | +18.2% |
| Q2 2023 | $4,042,994 | +166.3% | 282,332 | +32.8% | 0.81% | +106.6% |
| Q1 2023 | $1,518,071 | -30.9% | 212,615 | +8.5% | 0.39% | -30.9% |
| Q4 2022 | $2,198,469 | +2.6% | 195,942 | +1.4% | 0.57% | +12.4% |
| Q3 2022 | $2,142,000 | +31.2% | 193,326 | 0.0% | 0.51% | +11.9% |
| Q2 2022 | $1,632,000 | -38.0% | 193,326 | 0.0% | 0.45% | -35.8% |
| Q1 2022 | $2,631,000 | – | 193,326 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $68,694,000 | 39.92% |
| Greenspring Associates, LLC | 360,939 | $11,990,000 | 15.57% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $193,587,000 | 14.91% |
| Abingworth LLP | 1,203,135 | $39,956,000 | 13.67% |
| Penn Mutual Asset Management | 86,940 | $2,888,000 | 2.55% |
| RA Capital Management | 3,825,008 | $127,067,000 | 1.78% |
| LUMINUS MANAGEMENT LLC | 126,903 | $4,216,000 | 0.98% |
| Pinz Capital Management, LP | 33,600 | $1,116,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 175,000 | $5,814,000 | 0.47% |
| Summit Rock Advisors, LP | 34,350 | $1,141,000 | 0.40% |